Cargando…
Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial
OBJECTIVES: We tested whether complementary use of the somatostatin analogue pasireotide would augment efficacy of aspiration sclerotherapy of hepatic cysts. METHODS: We conducted a double-blind, placebo-controlled trial in patients who underwent aspiration sclerotherapy of a large (>5 cm) sympto...
Autores principales: | Wijnands, Titus F. M., Gevers, Tom J. G., Lantinga, Marten A., te Morsche, René H., Schultze Kool, Leo J., Drenth, Joost P. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938297/ https://www.ncbi.nlm.nih.gov/pubmed/29318424 http://dx.doi.org/10.1007/s00330-017-5205-1 |
Ejemplares similares
-
Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data
por: Wijnands, Titus F. M., et al.
Publicado: (2016) -
Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial
por: Wijnands, Titus FM, et al.
Publicado: (2015) -
Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts
por: Neijenhuis, Myrte K., et al.
Publicado: (2018) -
Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts
por: Wijnands, Titus FM, et al.
Publicado: (2018) -
Aspiration–sclerotherapy Results in Effective Control of Liver Volume in Patients with Liver Cysts
por: van Keimpema, Loes, et al.
Publicado: (2008)